Detalles de la búsqueda
1.
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial.
Diabetes Obes Metab;
25(3): 844-855, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484428
2.
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes.
Diabetes Obes Metab;
25(10): 2888-2896, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395341
3.
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial.
Diabetes;
71(4): 812-820, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061894
4.
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial.
Int J Cardiovasc Imaging;
38(3): 579-587, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34669059
5.
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial.
J Am Heart Assoc;
10(15): e020418, 2021 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278803
6.
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).
BMJ Open;
9(11): e029098, 2019 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31780586
Resultados
1 -
6
de 6
1
Próxima >
>>